387-42-9 Purity
---
If you have any other questions or need other size, please get a quote.
Reference: [1]Ranatunge, Ramani R.; Garvey, David S.; Janero, David R.; Letts, L. Gordon; Martino, Allison M.; Murty, Madhavi G.; Richardson, Stewart K.; Young, Delano V.; Zemetseva, Irina S.
[Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 6, p. 1357 - 1366]
[2]van der Zanden et al.
[Recueil des Travaux Chimiques des Pays-Bas, 1957, vol. 76, p. 669,671]
Reference: [1] Patent: US2013/245272, 2013, A1, . Location in patent: Paragraph 0099
Reference: [1] European Journal of Medicinal Chemistry, 2009, vol. 44, # 2, p. 551 - 557
[2] Patent: US5270313, 1993, A,
[3] Journal of Chemical Crystallography, 2010, vol. 40, # 1, p. 25 - 28
Reference: [1] Patent: WO2012/66570, 2012, A2,
Reference: [1]Patent: US2003/88107,2003,A1
Reference: [1]European Journal of Medicinal Chemistry,2009,vol. 44,p. 551 - 557
[2]Patent: US5270313,1993,A
[3]Journal of Chemical Crystallography,2010,vol. 40,p. 25 - 28
* For details of the synthesis route, please refer to the original source to ensure accuracy.